The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EMN 2018 | Optimizing elderly MM patient treatment
Elderly patients with multiple myeloma (MM) are often denied intensive treatment due to the fear they will not be able to tolerate it. However, Mohamad Mohty, MD, PhD of the University Pierre & Marie Curie, Paris, France, explains how, with slight adjustments and refinements to the screening and treatment processes, many elderly patients, including those previously thought too frail, can successfully receive and respond to treatment. Speaking from the 1st European Myeloma Network (EMN) Meeting, in Turin, Italy, Prof. Mohty outlines how different elderly patients should be treated based on their fitness, rather than age, and states some of the appropriate treatments for patients varying in fitness.
